{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:06:24Z","timestamp":1790057184578,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T00:00:00Z","timestamp":1557619200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00259-019-04339-y","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T23:19:33Z","timestamp":1557789573000},"page":"1626-1632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Risk of ischaemic events at giant cell arteritis diagnosis according to PET\/CT findings"],"prefix":"10.1007","volume":"46","author":[{"given":"Jaume","family":"Mestre-Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Sim\u00f3-Perdig\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Mart\u00ednez-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Navales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Loureiro-Amigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roser","family":"Solans-Laque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,12]]},"reference":[{"key":"4339_CR1","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1136\/annrheumdis-2013-204652","volume":"74","author":"AJ Mohammad","year":"2015","unstructured":"Mohammad AJ, Nilsson JA, Jacobsson LT, Merkel PA, Turesson C. Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden. Ann Rheum Dis. 2015;74:993\u20137.","journal-title":"Ann Rheum Dis"},{"key":"4339_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3109\/03009742.2014.982701","volume":"44","author":"AK Chandran","year":"2015","unstructured":"Chandran AK, Udayakumar PD, Crowson CS, Warrington KJ, Matteson EL. The incidence of giant cell arteritis in Olmsted County Minnesota, over a sixty year period 1950-2009. Scand J Rheumatol. 2015;44:215\u20138.","journal-title":"Scand J Rheumatol"},{"key":"4339_CR3","doi-asserted-by":"publisher","first-page":"A544","DOI":"10.1016\/j.autrev.2012.01.003","volume":"11","author":"AT Borchers","year":"2012","unstructured":"Borchers AT, Gershwin ME. Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev. 2012;11:A544\u201354.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"4339_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/WNO.0b013e318268aa9b","volume":"32","author":"CM Weyand","year":"2012","unstructured":"Weyand CM, Liao YJ, Goronzy JJ. The immunopathology of giant cell arteritis: diagnostic and therapeutic implications. J Neuroophthalmol. 2012;32(3):259\u201365.","journal-title":"J Neuroophthalmol"},{"key":"4339_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jaut.2016.03.005","volume":"69","author":"F Muratore","year":"2016","unstructured":"Muratore F, Boiardi L, Cavazza A, Aldigeri R, Pipitone N, Restuccia G, et al. Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis. J Autoimmun. 2016;69:94\u2013101.","journal-title":"J Autoimmun"},{"issue":"5","key":"4339_CR6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/00005792-199909000-00002","volume":"78","author":"MA Gonzalez-Gay","year":"1999","unstructured":"Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects. Medicine (Baltimore). 1999;78(5):292\u2013308.","journal-title":"Medicine (Baltimore)"},{"key":"4339_CR7","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.1780330810","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122\u20138.","journal-title":"Arthritis Rheum"},{"key":"4339_CR8","doi-asserted-by":"publisher","first-page":"e3818","DOI":"10.1097\/MD.0000000000003818","volume":"95","author":"H de Boysson","year":"2016","unstructured":"de Boysson H, Lambert M, Liozon E, Boutemy J, Maign\u00e9 G, Olivier Y, et al. Giant-cell arteritis without cranial manifestations: working diagnosis of a distinct disease pattern. Medicine (Baltimore). 2016;95:e3818.","journal-title":"Medicine (Baltimore)"},{"key":"4339_CR9","first-page":"S77","volume":"27","author":"J P\u00e9rez L\u00f3pez","year":"2009","unstructured":"P\u00e9rez L\u00f3pez J, Solans Laqu\u00e9 R, Bosch Gil JA, Molina Cateriano C, Huguet Redecilla P, Vilardell Tarr\u00e9s M. Colour-duplex ultrasonography of the temporal and ophthalmic arteries in the diagnosis and follow-up of giant cell arteritis. Clin Exp Rheumatol. 2009;27:S77\u201382.","journal-title":"Clin Exp Rheumatol"},{"key":"4339_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1024\/0301-1526\/a000096","volume":"40","author":"S F\u00f6rster","year":"2011","unstructured":"F\u00f6rster S, Tato F, Weiss M, Czihal M, Rominger A, Bartenstein P, et al. Patterns of extracranial involvement in newly diagnosed giant cell arteritis assessed by physical examination, colour coded duplex sonography and FDG-PET. Vasa. 2011;40:219\u201327.","journal-title":"Vasa"},{"key":"4339_CR11","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1007\/s00393-015-1674-2","volume":"75","author":"Y Lee","year":"2016","unstructured":"Lee Y, Choi S, Ji J, Song G. Diagnostic accuracy of 18F-FDG PET or PET\/CT for large vessel vasculitis: a meta-analysis. Z Rheumatol. 2016;75:924\u201331.","journal-title":"Z Rheumatol"},{"key":"4339_CR12","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","volume":"77","author":"C Dejaco","year":"2018","unstructured":"Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77:636\u201343.","journal-title":"Ann Rheum Dis"},{"key":"4339_CR13","doi-asserted-by":"publisher","first-page":"e3851","DOI":"10.1097\/MD.0000000000003851","volume":"95","author":"H de Boysson","year":"2016","unstructured":"de Boysson H, Liozon E, Lambert M, Parienti J-J, Artigues N, Gefrray L, et al. 18F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis. Medicine (Baltimore). 2016;95:e3851.","journal-title":"Medicine (Baltimore)"},{"key":"4339_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/rheumatology\/keu329","volume":"54","author":"F Muratore","year":"2015","unstructured":"Muratore F, Kermani TA, Crowson CS, Green AB, Salvarani C, Matteson EL, et al. Large-vessel giant cell arteritis: A cohort study. Rheumatology (Oxford). 2015;54:463\u201370.","journal-title":"Rheumatology (Oxford)"},{"key":"4339_CR15","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00259-018-4021-4","volume":"45","author":"BD Nielsen","year":"2018","unstructured":"Nielsen BD, Gormsen LC, Hansen IT, Keller KK, Therkildsen P, Hauge EM. Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy. Eur J Nucl Med Mol Imaging. 2018;45:1119\u201328.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4339_CR16","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.3899\/jrheum.170138","volume":"44","author":"AH Clifford","year":"2017","unstructured":"Clifford AH, Murphy EM, Burrell SC, Bligh MP, MacDougall RF, Heathcote JG, et al. Positron emission tomography\/computerized tomography in newly diagnosed patients with giant cell arteritis who are taking glucocorticoids. J Rheumatol. 2017;44:1859\u201366.","journal-title":"J Rheumatol"},{"key":"4339_CR17","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1007\/s00259-018-3973-8","volume":"45","author":"RH Slart","year":"2018","unstructured":"Slart RH. FDG-PET\/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging. 2018;45:1250\u201369.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4339_CR18","doi-asserted-by":"crossref","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1\u201311.","DOI":"10.1002\/art.37715"},{"key":"4339_CR19","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/art.40520","volume":"70","author":"KSM van der Geest","year":"2018","unstructured":"van der Geest KSM, Sandovici M, van Sleen Y, Sanders J, Bos NA, Abdulahad WH, et al. What is the current evidence for disease subsets in giant cell arteritis? Arthritis Rheum. 2018;70:1366\u201376.","journal-title":"Arthritis Rheum"},{"key":"4339_CR20","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1136\/annrheumdis-2013-204572","volume":"73","author":"S Prieto-gonz\u00e1lez","year":"2014","unstructured":"Prieto-gonz\u00e1lez S, Depetris M, Garc\u00eda-mart\u00ednez A, Esp\u00edgol-frigol\u00e9 G, Tavera-bahillo I, Corbera-bellata M, et al. Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study. Ann Rheum Dis. 2014;73:1388\u201392.","journal-title":"Ann Rheum Dis"},{"key":"4339_CR21","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.berh.2016.09.010","volume":"30","author":"F Muratore","year":"2016","unstructured":"Muratore F, Pipitone N, Salvarani C, Schmidt WA. Imaging of vasculitis: state of the art. Best Pract Res Clin Rheumatol. 2016;30:688\u2013706.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4339_CR22","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.autrev.2017.09.008","volume":"16","author":"M Hommada","year":"2017","unstructured":"Hommada M, Mekinian A, Brillet P, Larroche C, Dh\u00f4te R, Fain O. Aortitis in giant cell arteritis: diagnosis with FDG PET\/CT and agreement with CT angiography. Autoimmun Rev. 2017;16:1131\u20137.","journal-title":"Autoimmun Rev"},{"issue":"8","key":"4339_CR23","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/rheumatology\/ken119","volume":"47","author":"D Blockmans","year":"2008","unstructured":"Blockmans D, Coudyzer W, Vanderschueren S, Stroobants S, Loeckx D, Heye S, et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology. 2008;47(8):1179\u201384.","journal-title":"Rheumatology"},{"issue":"5","key":"4339_CR24","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/art.23577","volume":"59","author":"C Agard","year":"2008","unstructured":"Agard C, Barrier JH, Dupas B, Ponge T, Mahr A, Fradet G, et al. Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Care Res. 2008;59(5):670\u20136.","journal-title":"Arthritis Care Res"},{"key":"4339_CR25","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/ehjci\/jex259","volume":"19","author":"S Imfeld","year":"2018","unstructured":"Imfeld S, Rottenburger C, Schegk E, Aschwanden M, Juengling F, Staub D, et al. [18-F] FDG positron emission tomography in patients presenting with suspicion of giant cell arteritis \u2013 lessons from a vasculitis clinic. Eur Heart J Cardiovasc Imaging. 2018;19:933\u201340.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"4339_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/01.md.0000145369.25558.b5","volume":"83","author":"MA Gonzalez-Gay","year":"2004","unstructured":"Gonzalez-Gay MA, Pi\u00f1eiro A, Gomez-Gigirey A, Garcia-Porrua C, Pego-Reigosa R, Dierssen-Sotos T, et al. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore). 2004;83:342\u20137.","journal-title":"Medicine (Baltimore)"},{"issue":"6 Suppl 36","key":"4339_CR27","first-page":"S13","volume":"22","author":"R Pego-Reigosa","year":"2004","unstructured":"Pego-Reigosa R, Garcia-Porrua C, Pineiro A, Dierssen T, Llorca J, Gonzalez-Gay MA. Predictors of cerebrovascular accidents in giant cell arteritis in a defined population. Clin Exp Rheumatol. 2004;22(6 Suppl 36):S13\u20137.","journal-title":"Clin Exp Rheumatol"},{"key":"4339_CR28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/rheumatology\/ken465","volume":"48","author":"C Salvarani","year":"2009","unstructured":"Salvarani C, Della Bella C, Cimino L, Macchioni P, Formisano D, Bajocchi G, et al. Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis. Rheumatology. 2009;48:250\u20133.","journal-title":"Rheumatology"},{"issue":"7","key":"4339_CR29","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3899\/jrheum.151135","volume":"43","author":"E Liozon","year":"2016","unstructured":"Liozon E, Dalmay F, Lalloue F, Gondran G, Bezanahary H, Fauchais AL, et al. Risk factors for permanent visual loss in biopsy-proven giant cell arteritis: A study of 339 patients. J Rheumatol. 2016;43(7):1393\u20139.","journal-title":"J Rheumatol"},{"key":"4339_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/rheumatology\/ken515","volume":"48","author":"WA Schmidt","year":"2009","unstructured":"Schmidt WA, Krause A, Schicke B, Kuchenbecker J, Gromnica-Ihle E. Do temporal artery duplex ultrasound findings correlate with ophthalmic complications in giant cell arteritis? Rheumatology. 2009;48:383\u20135.","journal-title":"Rheumatology"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04339-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-019-04339-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04339-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T19:07:50Z","timestamp":1589137670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-019-04339-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,12]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["4339"],"URL":"https:\/\/doi.org\/10.1007\/s00259-019-04339-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,12]]},"assertion":[{"value":"29 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The protocol was approved by the Ethics Committee of the Hospital Vall d\u2019Hebron.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}